Study Quantifies Risk Factors for Preterm Birth
CINCINNATI -- A significant portion of preterm births might be avoided by reducing or eliminating three major risk factors.
A new Cincinnati Children's Hospital Medical Center study shows that as many as 25 percent of preterm births might be attributed to abnormalities in the interval between pregnancies, the mother's body mass index prior to pregnancy, and the amount of weight gain in pregnancy. All of these risk factors may be modifiable to reduce the risk of premature births - those before 37 weeks of gestation.
The study is published online in the Maternal and Child Health Journal.
"The highest risks for premature birth were in women who were underweight, had poor weight gain during pregnancy, or short periods of time between pregnancies," says Emily DeFranco, DO, a physician-researcher at the Center for Prevention of Preterm Birth at Cincinnati Children's and an associate professor of maternal-fetal medicine at the University of Cincinnati College of Medicine. "However, excessive weight gain in obese women also increased the risk."
DeFranco and her colleagues conducted the study from birth records in Ohio from 2006 to 2011. Nearly 400,000 live, non-multiple births were included. Potentially modifiable risk factors for preterm birth were present in more than 90 percent of women in the study. Fewer than half of women begin pregnancy with a normal weight, and only 32 percent achieve the recommended pregnancy weight gain.
"Attention should be paid to educational interventions on the importance of birth spacing, achieving an optimal pre-pregnancy weight, and ensuring adequate nutrition and weight gain during pregnancy," says DeFranco. "Improvements in these modifiable risk factors could have significant influence on premature birth and infant mortality worldwide."
According to the March of Dimes, the rate of preterm birth in the United States is 12 percent. This is above the global average of 11.1 percent.
The research was funded in part by the March of Dimes.
Related Stories
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.
Phase 1 trial tests probiotic treatment for radiation side effects in the gut
March 9, 2026
The University of Cincinnati Cancer Center’s Bailey Nelson, MD, has been awarded a $50,000 pilot grant from the Cancer Center to open a Phase 1 trial testing if a probiotic supplement can reduce gastrointestinal symptoms for patients undergoing whole pelvis radiotherapy.
Is uACR the key to cardiovascular and kidney disease prevention?
March 8, 2026
As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.